Your browser doesn't support javascript.
loading
Pakistan Journal of Pharmaceutical Sciences. 2018; 31 (3): 769-775
en Inglés | IMEMR | ID: emr-198660
ABSTRACT
Helicobacter pylori [H. pylori] infections are very serious health problem that are further worsened by increasing/developing resistance to the current antibiotics. Therefore, new therapeutic agents are needed for H. pylori eradication. Use of a CD46 derived peptide [P3] as bactericidal agent against H. pylori has shown high activity rate in vivo and this study examines the changes in H. pylori features in response to effect of P3 treatment.AGS cells were infected with H. pylori wild type strain 6721 and its mice passage strains [P3 treated and untreated strains] and further examined using immunoblotting assay, FACS and Urease activity analysis. Comparatively we found increased level of Urease alpha subunit A [UreA] and alkyl hydroperoxide reductase C [AhpC] proteins for P3 treated strain of H. pylori than its wild type or untreated strain after infection of AGS cells. Conclusion These results suggest that there might be a high rate of adherence to host cells for the P3 treated passage strain than untreated or wild type strain. Our findings also indicate that either adhesins are being changed or H. pylori interaction to the host cells is affected after P3 treatment
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Pak. J. Pharm. Sci. Año: 2018

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Idioma: Inglés Revista: Pak. J. Pharm. Sci. Año: 2018